{"product_id":"mce-conferences-dermatology-and-womens-health-for-primary-care-jul-10-2026-jul-12-2026","title":"MCE Conferences Dermatology and Women’s Health for Primary Care Jul 10, 2026 – Jul 12, 2026","description":"\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\r\n\u003ch1\u003eMCE Conferences Dermatology \u0026amp; Women's Health for Primary Care 2026 (Videos)\u003c\/h1\u003e\r\n\u003ch2\u003eComprehensive Primary Care Updates in Dermatology, Women's Health, Skin Cancer, Acne, Rosacea, Menopause, Contraception, HPV, PCOS, Vaginitis, and Evidence-Based Outpatient Care\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eExpand your expertise in two of the most frequently encountered disciplines in outpatient medicine with \u003cstrong\u003eMCE Conferences Dermatology \u0026amp; Women's Health for Primary Care 2026\u003c\/strong\u003e, a comprehensive continuing medical education (CME) program designed specifically for primary care clinicians. This evidence-based conference provides practical clinical updates in dermatology and women's health, emphasizing accurate diagnosis, current treatment guidelines, preventive care, and patient-centered management strategies for conditions commonly encountered in everyday practice.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eHeld \u003cstrong\u003eJuly 10–12, 2026\u003c\/strong\u003e, at the \u003cstrong\u003eLido Beach Resort, Lido Key, Sarasota, Florida\u003c\/strong\u003e, this interactive educational program combines expert-led lectures, case-based discussions, and hands-on clinical workshops to help healthcare professionals improve diagnostic confidence and therapeutic decision-making. Participants receive the latest evidence on skin disorders, skin cancer recognition, women's preventive healthcare, contraception, menopause, gynecologic conditions, sexually transmitted infections, and dermatologic diseases affecting diverse patient populations.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThrough practical, guideline-based education, clinicians gain immediately applicable knowledge that enhances patient outcomes while strengthening preventive care across all stages of women's health and office dermatology.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eProduct Details\u003c\/h1\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e Dermatology \u0026amp; Women's Health for Primary Care 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eProvider:\u003c\/strong\u003e MCE Conferences\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eConference Dates:\u003c\/strong\u003e July 10–12, 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLocation:\u003c\/strong\u003e Lido Beach Resort, Lido Key, Sarasota, Florida, USA\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Videos\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCME Credits:\u003c\/strong\u003e 12 CME Credits\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Level:\u003c\/strong\u003e Intermediate to Advanced\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLearning Format:\u003c\/strong\u003e Expert Lectures, Case-Based Learning, Interactive Discussions, Hands-On Workshops\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eCourse Overview\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eDermatologic diseases and women's health concerns account for a significant proportion of visits in primary care. Because advances in dermatologic therapeutics, gynecologic care, contraception, cervical cancer screening, menopause management, and preventive medicine continue to evolve rapidly, clinicians must remain current with the latest evidence-based recommendations.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003eMCE Dermatology \u0026amp; Women's Health for Primary Care 2026\u003c\/strong\u003e provides a practical, multidisciplinary review of common outpatient conditions affecting patients across all age groups. Faculty members present contemporary approaches to evaluating skin lesions, diagnosing inflammatory skin diseases, managing gynecologic disorders, optimizing contraceptive counseling, improving menopause care, and recognizing systemic diseases through dermatologic manifestations.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe curriculum emphasizes efficient office-based diagnosis, individualized treatment planning, patient counseling, and timely specialist referral while integrating current recommendations from leading dermatology, gynecology, and preventive medicine guidelines.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhat You'll Learn\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eAfter completing this course, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDiagnose benign and malignant skin lesions and determine appropriate treatment or referral.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate acne vulgaris from rosacea using evidence-based clinical features.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize dermatologic manifestations of internal malignancies.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate chronic pruritus using structured diagnostic approaches.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove diagnosis and management of skin diseases in patients with skin of color.\u003c\/li\u003e\r\n \t\u003cli\u003eOptimize contraceptive counseling, including long-acting reversible contraception (LARC) and emergency contraception.\u003c\/li\u003e\r\n \t\u003cli\u003eApply current recommendations for menopausal hormone therapy (MHT).\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnose and manage HPV infection, cervical cancer screening abnormalities, vaginitis, PCOS, and female sexual dysfunction.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eComprehensive Topics Covered\u003c\/h1\u003e\r\n\u003ch2\u003eOffice Dermatology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eStrengthen diagnostic accuracy for common dermatologic disorders encountered in primary care.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOffice dermatology\u003c\/li\u003e\r\n \t\u003cli\u003eSkin examination\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologic procedures\u003c\/li\u003e\r\n \t\u003cli\u003eSkin lesion evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-based treatment\u003c\/li\u003e\r\n \t\u003cli\u003eClinical decision-making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eFaculty emphasize practical strategies that improve office-based dermatologic care.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eSkin Cancer \u0026amp; Cutaneous Neoplasms\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eImprove early recognition of benign and malignant skin lesions.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBasal cell carcinoma\u003c\/li\u003e\r\n \t\u003cli\u003eSquamous cell carcinoma\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma\u003c\/li\u003e\r\n \t\u003cli\u003eActinic keratosis\u003c\/li\u003e\r\n \t\u003cli\u003eBenign skin neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eSkin biopsy\u003c\/li\u003e\r\n \t\u003cli\u003eReferral indications\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eParticipants learn evidence-based approaches to diagnosis, treatment selection, and timely specialist referral.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eAcne \u0026amp; Rosacea\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eDevelop confidence in distinguishing common inflammatory skin disorders.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAcne vulgaris\u003c\/li\u003e\r\n \t\u003cli\u003eRosacea\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eTopical therapies\u003c\/li\u003e\r\n \t\u003cli\u003eOral medications\u003c\/li\u003e\r\n \t\u003cli\u003eChronic disease management\u003c\/li\u003e\r\n \t\u003cli\u003ePatient counseling\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003ePruritus \u0026amp; General Dermatology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eMaster evaluation of patients presenting with itching and diffuse skin disease.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eChronic pruritus\u003c\/li\u003e\r\n \t\u003cli\u003eAtopic dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eContact dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eUrticaria\u003c\/li\u003e\r\n \t\u003cli\u003eXerosis\u003c\/li\u003e\r\n \t\u003cli\u003eSystemic causes of itch\u003c\/li\u003e\r\n \t\u003cli\u003eSymptom management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eSkin of Color Dermatology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eEnhance culturally competent dermatologic care.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSkin of color\u003c\/li\u003e\r\n \t\u003cli\u003ePigmentary disorders\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eCultural skin practices\u003c\/li\u003e\r\n \t\u003cli\u003eHair disorders\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic differences\u003c\/li\u003e\r\n \t\u003cli\u003eTherapeutic considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eFaculty discuss how common dermatologic diseases present differently across diverse skin types.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eCutaneous Manifestations of Systemic Disease\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eRecognize important skin findings associated with internal disease.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCutaneous metastases\u003c\/li\u003e\r\n \t\u003cli\u003eParaneoplastic syndromes\u003c\/li\u003e\r\n \t\u003cli\u003eInternal malignancy\u003c\/li\u003e\r\n \t\u003cli\u003eAutoimmune disease\u003c\/li\u003e\r\n \t\u003cli\u003eSystemic disorders\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologic warning signs\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic clues\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eContraception \u0026amp; Family Planning\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eProvide individualized contraceptive counseling using current clinical guidelines.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLong-acting reversible contraception (LARC)\u003c\/li\u003e\r\n \t\u003cli\u003eCombined oral contraceptives\u003c\/li\u003e\r\n \t\u003cli\u003eProgestin-only contraception\u003c\/li\u003e\r\n \t\u003cli\u003eEmergency contraception\u003c\/li\u003e\r\n \t\u003cli\u003eContraceptive selection\u003c\/li\u003e\r\n \t\u003cli\u003ePatient counseling\u003c\/li\u003e\r\n \t\u003cli\u003eShared decision-making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMenopause \u0026amp; Menopausal Hormone Therapy\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview evidence-based management of menopausal symptoms.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n \t\u003cli\u003eMenopausal hormone therapy (MHT)\u003c\/li\u003e\r\n \t\u003cli\u003eVasomotor symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eCardiovascular risk\u003c\/li\u003e\r\n \t\u003cli\u003eBreast cancer risk\u003c\/li\u003e\r\n \t\u003cli\u003eBone health\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized therapy\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eHPV \u0026amp; Cervical Cancer Prevention\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eStrengthen preventive gynecologic care.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHuman papillomavirus (HPV)\u003c\/li\u003e\r\n \t\u003cli\u003eCervical cancer screening\u003c\/li\u003e\r\n \t\u003cli\u003ePap testing\u003c\/li\u003e\r\n \t\u003cli\u003eHPV testing\u003c\/li\u003e\r\n \t\u003cli\u003eCervical dysplasia\u003c\/li\u003e\r\n \t\u003cli\u003eVaccination\u003c\/li\u003e\r\n \t\u003cli\u003eScreening guidelines\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eVaginitis \u0026amp; Vaginal Disorders\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eImprove diagnosis of common vaginal conditions.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBacterial vaginosis\u003c\/li\u003e\r\n \t\u003cli\u003eVulvovaginal candidiasis\u003c\/li\u003e\r\n \t\u003cli\u003eTrichomoniasis\u003c\/li\u003e\r\n \t\u003cli\u003ePersistent vaginitis\u003c\/li\u003e\r\n \t\u003cli\u003eVaginal discharge\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic testing\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-based treatment\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003ePolycystic Ovary Syndrome (PCOS)\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview diagnosis and multidisciplinary management of PCOS.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePolycystic ovary syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eHyperandrogenism\u003c\/li\u003e\r\n \t\u003cli\u003eOvulatory dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eMetabolic syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eInsulin resistance\u003c\/li\u003e\r\n \t\u003cli\u003eFertility\u003c\/li\u003e\r\n \t\u003cli\u003eLong-term management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eFemale Sexual Health\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eEnhance assessment and management of female sexual dysfunction.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFemale sexual dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eHypoactive sexual desire disorder\u003c\/li\u003e\r\n \t\u003cli\u003eSexual response cycle\u003c\/li\u003e\r\n \t\u003cli\u003eDyspareunia\u003c\/li\u003e\r\n \t\u003cli\u003eCounseling\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal therapy\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-centered care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eLearning Objectives\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eUpon completion of this educational activity, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDiagnose common benign and malignant skin neoplasms while selecting appropriate destructive therapies or specialty referral.\u003c\/li\u003e\r\n \t\u003cli\u003eOptimize contraceptive counseling using long-acting reversible contraception, combination contraceptives, and emergency contraception.\u003c\/li\u003e\r\n \t\u003cli\u003eApply current evidence regarding menopausal hormone therapy, cardiovascular risk, and breast cancer risk.\u003c\/li\u003e\r\n \t\u003cli\u003eImplement current cervical cancer screening recommendations using Pap testing and HPV testing.\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnose persistent and treatment-resistant vaginitis using evidence-based diagnostic strategies.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate acne vulgaris from rosacea and apply appropriate treatment approaches.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize cutaneous manifestations of internal malignancy and metastatic disease.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate chronic pruritus using systematic diagnostic approaches.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove dermatologic care for patients with skin of color.\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnose and manage polycystic ovary syndrome (PCOS) and female sexual dysfunction using contemporary clinical guidelines.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eEducational Highlights\u003c\/h1\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePrimary Care Dermatology\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Health\u003c\/li\u003e\r\n \t\u003cli\u003eSkin Cancer\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma\u003c\/li\u003e\r\n \t\u003cli\u003eAcne Vulgaris\u003c\/li\u003e\r\n \t\u003cli\u003eRosacea\u003c\/li\u003e\r\n \t\u003cli\u003eChronic Pruritus\u003c\/li\u003e\r\n \t\u003cli\u003eSkin of Color\u003c\/li\u003e\r\n \t\u003cli\u003eHuman Papillomavirus (HPV)\u003c\/li\u003e\r\n \t\u003cli\u003eCervical Cancer Screening\u003c\/li\u003e\r\n \t\u003cli\u003ePap Testing\u003c\/li\u003e\r\n \t\u003cli\u003eLong-Acting Reversible Contraception (LARC)\u003c\/li\u003e\r\n \t\u003cli\u003eMenopausal Hormone Therapy (MHT)\u003c\/li\u003e\r\n \t\u003cli\u003eVaginitis\u003c\/li\u003e\r\n \t\u003cli\u003ePolycystic Ovary Syndrome (PCOS)\u003c\/li\u003e\r\n \t\u003cli\u003eFemale Sexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Gynecology\u003c\/li\u003e\r\n \t\u003cli\u003eOffice-Based Dermatology\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Primary Care\u003c\/li\u003e\r\n \t\u003cli\u003eContinuing Medical Education (CME)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhy This Course Stands Out\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003eMCE Conferences Dermatology \u0026amp; Women's Health for Primary Care 2026\u003c\/strong\u003e uniquely integrates two of the most essential disciplines in outpatient medicine into one comprehensive educational experience. Combining evidence-based dermatology, preventive gynecology, women's health, office procedures, and practical case-based learning, the conference equips clinicians with the knowledge needed to confidently diagnose, treat, counsel, and appropriately refer patients presenting with common skin disorders and women's health concerns. Its strong focus on real-world clinical decision-making makes it an outstanding educational resource for today's primary care providers.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eTarget Audience\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis educational activity is ideal for:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologists\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologists\u003c\/li\u003e\r\n \t\u003cli\u003eObstetrician-Gynecologists (OB\/GYN)\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Health Specialists\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician Assistants\u003c\/li\u003e\r\n \t\u003cli\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eUrgent Care Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine Residents\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine Residents\u003c\/li\u003e\r\n \t\u003cli\u003eHealthcare Professionals involved in outpatient dermatology and women's healthcare\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhy Choose This Course?\u003c\/h1\u003e\r\nWhether you practice primary care, family medicine, internal medicine, dermatology, or gynecology, \u003cstrong\u003eMCE Conferences Dermatology \u0026amp; Women's Health for Primary Care 2026\u003c\/strong\u003e provides one of the most practical and comprehensive educational updates available for office-based clinicians. Through expert-led lectures, interactive workshops, current clinical guidelines, and case-based discussions, participants gain the skills needed to improve dermatologic diagnosis, optimize women's preventive healthcare, deliver evidence-based treatment, and enhance patient outcomes across a wide spectrum of outpatient conditions.\r\n\u003cp data-path-to-node=\"4\"\u003e\u003cb data-path-to-node=\"4\" data-index-in-node=\"0\"\u003eTopics\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"5\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,0,0\"\u003e\u003cb data-path-to-node=\"5,0,0\" data-index-in-node=\"0\"\u003eBenign Skin Tumors\u003c\/b\u003e: Diagnose common benign skin neoplasms; Select proper destructive methods to eliminate benign skin tumors; Recognize serious systemic associations with benign skin neoplasms.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,1,0\"\u003e\u003cb data-path-to-node=\"5,1,0\" data-index-in-node=\"0\"\u003eMalignant Skin Tumors\u003c\/b\u003e: Diagnose the common malignant skin tumors; Determine the optimal approach to malignant skin tumors; Select cases that should be referred to specialty care.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,2,0\"\u003e\u003cb data-path-to-node=\"5,2,0\" data-index-in-node=\"0\"\u003eContraception 2026\u003c\/b\u003e: Describe the role of long-acting reversible contraception (LARC) in family planning; Discuss risks, benefits and counseling guidelines for long-acting methods; Discuss optimal prescribing of combination contraceptives, such as the pill, patch, and ring; Identify the available options for emergency contraception, including the benefits and limitations.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,3,0\"\u003e\u003cb data-path-to-node=\"5,3,0\" data-index-in-node=\"0\"\u003eMenopausal Hormone Therapy 2026\u003c\/b\u003e: Discuss data on the cardiovascular risks and benefits of MHT generated after the initial publication from the Women’s Health Initiative; Summarize current evidence regarding the effect of MHT on breast cancer risk; Identify current best practices for prescribing MHT.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,4,0\"\u003e\u003cb data-path-to-node=\"5,4,0\" data-index-in-node=\"0\"\u003eEvolving Guidelines for Pap and HPV Testing\u003c\/b\u003e: Describe the natural history of HPV infection and how it relates to current screening recommendations for cervi\u003cspan class=\"citation-6875 citation-end-6875\"\u003ecal neoplasia; Identify current guidelines for frequency of Pap testing; Describe the role of HPV testing in detecting cervical neoplasia.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,5,0\"\u003e\u003cb data-path-to-node=\"5,5,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-6874\"\u003eVaginitis: Tackling the Tough Cases\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-6874 citation-end-6874\"\u003e: Discuss the roles for, and limitations of, the tests currently available for the diagnosis of vaginal infections; Describe current recommendations and options for managi\u003c\/span\u003eng persistent and resistant vaginitis; Identify entities, othe\u003cspan class=\"citation-6873 citation-end-6873\"\u003er than vaginitis, that may be associated with vaginal symptoms.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,6,0\"\u003e\u003cb data-path-to-node=\"5,6,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-6872\"\u003eAcne\/Rosacea Primer\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-6872 citation-end-6872\"\u003e: Clinically differentiate acne from rosacea; Identify differences in etiology between acne and rosacea; Employ proper treatments for both acne and r\u003c\/span\u003eosacea.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,7,0\"\u003e\u003cb data-path-to-node=\"5,7,0\" data-index-in-node=\"0\"\u003eCutaneous Signs of Internal Malignancy\u003c\/b\u003e: Recognize criter\u003cspan class=\"citation-6871 citation-end-6871\"\u003eia for skin findings to be signs of internal malignancy; Identify the most common cutaneous signs of internal malignancy; Enhance awareness of cutaneous metastatic disease.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,8,0\"\u003e\u003cb data-path-to-node=\"5,8,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-6870\"\u003eThe Itchy Patient\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-6870 citation-end-6870\"\u003e: Classify itchy patients into clinical gr\u003c\/span\u003eoups, which suggest etiology; Recognize where \u003cspan class=\"citation-6869 citation-end-6869\"\u003eto look and what to look for when patients present with pruritus; Manage the symptom of itch.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,9,0\"\u003e\u003cb data-path-to-node=\"5,9,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-6868\"\u003eSkin Disease in Skin of Color\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-6868 citation-end-6868\"\u003e: Recognize how common diseases may appear differently in skin of color patients; Identify and manage select skin diseases more common or unique to skin of c\u003c\/span\u003eolor patients; Discuss effects of cultural and medical practices on skin disease in skin of color patients.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,10,0\"\u003e\u003cb data-path-to-node=\"5,10,0\" data-index-in-node=\"0\"\u003ePolycystic Ovary Syndrome Simplified (Polyendocrine Metabolic Ovarian Syndrome)\u003c\/b\u003e: Describe the proposed pathophysiology of polycystic ovary syndrome; Identify management options for the gynecologic consequences of polycystic ovary syndrome, such as irregular menses, hirsutism, and infertility; Identify management options for the metabolic effects of polycystic ovary syndrome.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"5,11,0\"\u003e\u003cb data-path-to-node=\"5,11,0\" data-index-in-node=\"0\"\u003eFemale Sexual Dysfunction\u003c\/b\u003e: Describe the current model of normal female sexual response; Identify the diagnostic categories for female sexual dysfunction and discuss possible etiologies for each; Discuss management options for each category of female sexual dysfunction.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43163712815202,"sku":"MED-AMB09728","price":125.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/MCE-Conferences-Dermatology-and-Womens-Health-for-Primary-Care-Jul-10-2026-_E2_80_93-Jul-12-2026.jpg?v=1785419572","url":"https:\/\/meducourse.com\/products\/mce-conferences-dermatology-and-womens-health-for-primary-care-jul-10-2026-jul-12-2026","provider":"Meducourse","version":"1.0","type":"link"}